The nominations for this year's The Pathologist Power List are open.
06/08/2020 | Sponsored by Adaptive Biotechnologies
Minimal residual disease testing by immunosequencing can yield vital information about patients’ disease and management
06/04/2020 | Sponsored by Thermo Fisher Scientific
In-house testing offers labs the ability to research, educate, and achieve complete coordination with clinical colleagues
05/11/2020 | Sponsored by Thermo Fisher Scientific
A comparison of commonly used NGS assays for the detection of fusion genes based on a recent educational webinar
05/10/2020 | Sponsored by Thermo Fisher Scientific
An interview with Ruthy Shaco-Levy to explore why in-house laboratory is a valuable resource for both clinicians and patients
04/26/2020 | Michael Schubert
Researchers have catalogued almost every NUDT15 variant to understand patients’ likelihood of thiopurine toxicity
04/24/2020 | David Fenstermacher
Precision medicine is creating a sea change in healthcare and biomedical research. Is your lab prepared for the approaching tsunami of genetic tests?
03/23/2020 | Alexandra Pender, Natacha Entz-Werle
New ctDNA biomarkers could lead to more informed treatment decisions for patients with advanced non-small cell lung cancer and pediatric osteosarcoma
03/12/2020 | Luke Turner
A new initiative for translational genomics is set to boost genetic research and inspire the next generation of scientists in Africa
01/15/2020 | David Rimm
David Rimm continues the conversation about the best assay for atezolizumab after a recent response to his original article
12/11/2019 | Sponsored by Thermo Fisher Scientific
How valuable can it be to receive fully automated NGS results in a single day? A group of experts share their views
Register to access our FREE online portfolio, request the magazine in print and manage your preferences.
Register
To Screen, or not to Screen?
Women in Pathology
The Matchmakers